BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30708129)

  • 1. Spinal macrophage migration inhibitory factor and high mobility group box 1 mediate persistent bladder pain.
    Ma F; Meyer-Siegler KL; Leng L; Bucala R; Vera PL
    Neurosci Lett; 2019 Apr; 699():54-58. PubMed ID: 30708129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor mediates protease-activated receptor 4-induced bladder pain through urothelial high mobility group box 1.
    Ma F; Kouzoukas DE; Meyer-Siegler KL; Hunt DE; Leng L; Bucala R; Vera PL
    Physiol Rep; 2017 Dec; 5(24):. PubMed ID: 29263120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.
    Kouzoukas DE; Ma F; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
    PLoS One; 2016; 11(3):e0152055. PubMed ID: 27010488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease activated-receptor 4 activation as a model of persistent bladder pain: Essential role of macrophage migration inhibitory factor and high mobility group box 1.
    Ma F; Hunt DE; Leng L; Bucala R; Meyer-Siegler KL; Vera PL
    Int J Urol; 2018 Oct; 25(10):887-893. PubMed ID: 30112848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study.
    Ye S; Agalave NM; Ma F; Mahmood DFD; Al-Grety A; Khoonsari PE; Leng L; Svensson CI; Bucala R; Kultima K; Vera PL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain.
    Ye S; Ma F; Mahmood DFD; Meyer-Siegler KL; Menard RE; Hunt DE; Leng L; Bucala R; Vera PL
    PLoS One; 2021; 16(8):e0255975. PubMed ID: 34424927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Migration Inhibitory Factor Mediates PAR-Induced Bladder Pain.
    Kouzoukas DE; Meyer-Siegler KL; Ma F; Westlund KN; Hunt DE; Vera PL
    PLoS One; 2015; 10(5):e0127628. PubMed ID: 26020638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder Oxidative Stress and HMGB1 Release Contribute to PAR4-Mediated Bladder Pain in Mice.
    Ye S; Ma F; Mahmood DFD; Meyer-Siegler KL; Leng L; Bucala R; Vera PL
    Front Syst Neurosci; 2022; 16():882493. PubMed ID: 35645739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
    Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
    BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous H
    Wang W; Bo Q; Du J; Yu X; Zhu K; Cui J; Zhao H; Wang Y; Shi B; Zhu Y
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1077-F1086. PubMed ID: 29357418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial Oxidative Stress and ERK Activation Mediate HMGB1-Induced Bladder Pain.
    Ye S; Mahmood DFD; Ma F; Leng L; Bucala R; Vera PL
    Cells; 2023 May; 12(10):. PubMed ID: 37408274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor is upregulated in an endotoxin-induced model of bladder inflammation in rats.
    Meyer-Siegler KL; Ordorica RC; Vera PL
    J Interferon Cytokine Res; 2004 Jan; 24(1):55-63. PubMed ID: 14980085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal high-mobility group box-1 induces long-lasting mechanical hypersensitivity through the toll-like receptor 4 and upregulation of interleukin-1β in activated astrocytes.
    Morioka N; Miyauchi K; Miyashita K; Kochi T; Zhang FF; Nakamura Y; Liu K; Wake H; Hisaoka-Nakashima K; Nishibori M; Nakata Y
    J Neurochem; 2019 Sep; 150(6):738-758. PubMed ID: 31273787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumbosacral spinal proteomic changes during PAR4-induced persistent bladder pain.
    Ye S; Agalave NM; Ma F; D Mahmood DF; Al-Grety A; Khoonsari PE; Svensson CI; Kultima K; Vera PL
    Neurosci Lett; 2024 Jan; 818():137563. PubMed ID: 38036085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrochloric acid induced changes in macrophage migration inhibitory factor in the bladder, peripheral and central nervous system of the rat.
    Vera PL; Ordorica RC; Meyer-Siegler KL
    J Urol; 2003 Aug; 170(2 Pt 1):623-7. PubMed ID: 12853844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma 1 receptor mediated HMGB1 expression in spinal cord is involved in the development of diabetic neuropathic pain.
    Wang X; Feng C; Qiao Y; Zhao X
    Neurosci Lett; 2018 Mar; 668():164-168. PubMed ID: 29421543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats.
    Qian J; Zhu Y; Bai L; Gao Y; Jiang M; Xing F; Zhang J; Zhao W; Gu H; Mi Y; Tao YX; Xu JT
    Neurotherapeutics; 2020 Apr; 17(2):722-742. PubMed ID: 31879851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes.
    Ren PC; Zhang Y; Zhang XD; An LJ; Lv HG; He J; Gao CJ; Sun XD
    Brain Res Bull; 2012 Jul; 88(4):332-7. PubMed ID: 22459482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis.
    Agalave NM; Larsson M; Abdelmoaty S; Su J; Baharpoor A; Lundbäck P; Palmblad K; Andersson U; Harris H; Svensson CI
    Pain; 2014 Sep; 155(9):1802-1813. PubMed ID: 24954167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural high-mobility group box 1 induces mechanical hypersensitivity through activation of spinal microglia: Involvement of glutamate-NMDA receptor dependent mechanism in spinal dorsal horn.
    Nakamura Y; Fukuta A; Miyashita K; Zhang FF; Wang D; Liu K; Wake H; Hisaoka-Nakashima K; Nishibori M; Morioka N
    Biochem Pharmacol; 2021 Apr; 186():114496. PubMed ID: 33667472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.